Wednesday, February 5, 2025

6:30 PM to 9:00 PM Eastern Time
 
Myeloproliferative Neoplasms (MPN) Rounds NYC
3 West Club
Grand Salon (3rd floor)
3 W 51st Street
New York, NY 10019
 
*Only one (1) person per medical technology/pharmaceutical company may register and attend the MPN rounds. A corporate email address is required.
 

Agenda

6:30 PM – Dinner and Networking
7:00 PM – Welcome and Overview of Program
John Mascarenhas, MD 
7:05 PM – Overview of LLS Resources
LLS Staff
7:10 PM – Case Presentation and Discussion on Management of "Lower-risk" Essential Thrombocythemia (ET) and Polycythemia Vera (PV)
Ghaith Abu-Zeinah, MD and Franco Castillo Tokumori, MD
7:35 PM – Case Presentation and Discussion on Optimizing Jak Inhibitor Therapy in Myelofibrosis
Noa Rippel, MD and Megan Metzger, MD
8:00 PM – Case Presentation and Discussion on Targeting Mastocytosis: Current and Emerging Strategies in Diagnosis, Risk Stratification and Treatment 
Katherine Linder, MD and Sarvarinder Gill, MD
8:25 PM – Case Presentation and Discussion on Newly Diagnosed Chronic Myeloid Leukemia (CML): Pros and Cons of the Approved Drugs
Karen Seiter, MD and Snigdha Ghanta, MBBS
8:50 PM – Q&A, Discussion and Wrap-up
All Faculty
9:00 PM – Conclusion
John Mascarenhas, MD 
 
 
 

Description

Live interactive continuing medical education activity for healthcare professionals in New York City and surrounding areas to discuss myeloproliferative neoplasms (MPNs) updates and challenges in treatment.

Target Audience

This activity is intended for hematologists-oncologists, medical oncologists, physician associates, advanced practice providers, nurses and pharmacists involved in the care of patients with myeloproliferative neoplasms (MPNs).

Educational Objectives

After completing this activity, participants will be better able to:
  • Explain the latest treatment options for myeloproliferative neoplasms (MPNs), including updates on clinical trials
  • Identify disparities and challenges in diagnosis and treatment of MPNs
  • Describe side effects of treatment and management strategies
  • Apply diagnostic criteria for a correct diagnosis and grade
  • Identify resources for patient education and support 

Advisory Group

John Mascarenhas, MD (Chair)
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
 
Ghaith Abu-Zeinah, MD
Weill Cornell Medicine
New York, NY
 
Swati Goel, MD
Albert Einstein College of Medicine
Bronx, NY
 
Marina Kremyanskaya, MD, PhD
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
 
James McCloskey, MD
John Theurer Cancer Center 
Hackensack University School of Medicine
Hackensack, NJ
 
Raajit K. Rampal, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY
 
Karen Seiter, MD
New York Medical College
Valhalla, NY

Faculty

John Mascarenhas, MD (Chair)
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
 
Ghaith Abu-Zeinah, MD
Weill Cornell Medicine
New York, NY
 
Franco Castillo Tokumori, MD
New York Presbyterian Hospital - Weill Cornell Medicine
New York, NY
 
Snigdha Ghanta, MBBS
Westchester Medical Center
Valhalla, NY
 
Sarvarinder Gill, MD
John Theurer Cancer Center
Hackensack University Medical Center
Hackensack, NJ
 
Katherine Linder, MD
John Theurer Cancer Center
Hackensack Meridian Medical Center
Hackensack, NJ
 
Megan Metzger, MD
Icahn School of Medicine at Mount Sinai 
New York, NY
 
Noa Rippel, MD
Icahn School of Medicine at Mount Sinai
New York, NY
 
Karen Seiter, MD
New York Medical College
Valhalla, NY
 
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).
 
There is no commercial support associated with this activity.
 

For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: Profeducation@LLS.org.

 

Follow LLS